A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)

Ain-Shams Journal of Anesthesiology

Table 8 Comparison between study groups as regards organism clearance after treatment

	Group A	Group B	x²	p value
No growth	27 (84.4%)	8 (25.0%)	20.43	< 0.001**
Resistance	2 (6.3%)	9 (28.1%)	4.952	0.036*
Superinfection	1 (3.1%)	7 (21.9%)	3.571	0048*
Resistance and superinfection	2 (6.3%)	8 (25.0%)	3.721	0.045*